Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia
2013-004773-27Phase 3Terminated
- Sponsor
- Children's Oncology Group
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mercaptopurine, dexamethasone, methotrexate, vincristine and folinic acid in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Primary endpoint: Primary endpoints per assigned therapeutic COG protocol. Started Jan 2014; status: terminated.
02
Drugs
mercaptopurinedexamethasonemethotrexatevincristinefolinic acid
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2013-004773-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004773-27.